About Philip Silverman
Philip Silverman is a secretary and director at Akava Therapeutics.
Philip Silverman first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Philip Silverman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Philip Silverman works with at each company, as listed on that company's latest Form D.
Akava Therapeutics Inc. · Form D, Feb 19, 2026
RS
Richard Silverman
Executive officer and director
CP
Charles Polsky
Executive officer and director
JN
Joseph Nolan
Director
BM
Brendan MacMillan
Director